We have a deep understanding of the complex issues that patients, caregivers and providers face, and the unique journeys they embark on in rare diseases. We don’t just learn about our audience; we immerse ourselves in their lives to find out what really makes them tick. We document and record their search for answers and life beyond diagnosis.
From our strategic approach for gathering behavioural insight to patient engagement, idea generation and execution we have it covered with innovative solutions that achieve measurable success for Pharma clients.
Client stories
We are fortunate to work with pharmaceutical and biotech companies big and small. Collaboration and transparency are core to how we operate.
We believe that by working effectively together we achieve a higher level of performance and a better quality output for you.
We chose to work with swii.ch as they demonstrated their unique approach of combining years of patient engagement experience with technical/digital competencies to ensure patients remain central to the solutions we develop.
At the time we were planning to develop a roadmap for our digital strategy for an ultra-rare neuromuscular disease, and the approach swii.ch recommended allowed us to develop a good understanding of the patient’s digital journey for information that enabled us to identify the gaps that exist in the specific disease area. Swii.ch effectively guided the team’s creative thinking around insights gathered through the first phase of the project which enabled us to deliver a plan to develop a structured digital ecosystem that we believe will empower patients and their families/caregivers with information and solutions to live their best lives.
Vice President EMEA - Lupin Neurosciences
I have been engaging with swii.ch in the last 18 months to utilise their services in patient engagement and consultancy. Throughout this time, they have delivered to me qualitative analyses, patient group research and strategic advice, and will be supporting me in 2022 with various patient and access-related activities.
I would not hesitate to recommend the team for their experience, counsel, transparency, delivery and ability to build good relationships with people both in and outside the company.
Director of Patient Engagement and Advocacy EMEA Alnylam Pharmaceuticals Europe
See our posts
See what we’ve been up to as well as the latest news and opinions in rare diseases
